Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.48 |
| ▸ | FDPS | P14324 | 3/20 | 0.46 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.44 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.44 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | LAP3 | P28838 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | GMNN | O75496 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1044719 | 1.00 | SMPD1 (0.59) | SMPD1PTPN1FDPSS1PR2S1PR1 | |
| SCHEMBL596695 | 1.00 | SMPD1 (0.59) | SMPD1PTPN1FDPSS1PR2S1PR1 | |
| SCHEMBL744377 | 1.00 | SMPD1 (0.59) | SMPD1PTPN1FDPSS1PR2S1PR1 | |
| SCHEMBL27542771 | 1.00 | SMPD1 (0.59) | SMPD1PTPN1FDPSS1PR2S1PR1 | |
| SCHEMBL27835477 | 1.00 | SMPD1 (0.59) | SMPD1PTPN1FDPSS1PR2S1PR1 | |
| SCHEMBL27699114 | 1.00 | SMPD1 (0.59) | SMPD1PTPN1FDPSS1PR2S1PR1 | |
| Water SCHEMBL27411638 | 0.98 | SMPD1 (0.57) | SMPD1PTPN1FDPSS1PR2S1PR1 | |
| SCHEMBL8160746 | 0.98 | SMPD1 (0.56) | SMPD1PTPN1FDPSS1PR2S1PR1 | |
| SCHEMBL4064805 | 0.91 | SMPD1 (0.50) | SMPD1PTPN1S1PR2S1PR1S1PR3 | |
| SCHEMBL3332099 | 0.91 | SMPD1 (0.50) | SMPD1PTPN1S1PR2S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119451386-A | Hole transport layer, perovskite solar cell and preparation method | 天合光能股份有限公司 | 2025-02-14 | — | — | CN | claimed |
| US-8703179-B2 | Mucosal formulation | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2014-04-22 | — | — | US | claimed |
| WO-2007133261-A1 | MUCOSAL FORMULATION | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2007-11-22 | — | — | WO | claimed |
| US-20070264206-A1 | Mucosal formulation | KIMBERLY-CLARK WORLDWIDE, INC. | 2007-11-15 | — | — | US | claimed |
| US-20050255556-A1 | Refolding of ion channel proteins | M-PHASYS GMBH (DE) | 2005-11-17 | — | — | US | claimed |
| US-20260097150-A1 | Implantable Device for Treating an Ocular Condition | CELANESE EVA PERFORMANCE POLYMERS LLC (US) | 2026-04-09 | — | — | US | disclosed |
| US-20260096984-A1 | Implantable Device for Administering a Therapeutic Agent | CELANESE EVA PERFORMANCE POLYMERS LLC (US) | 2026-04-09 | — | — | US | disclosed |
| US-20260096985-A1 | Injectable Composition For Drug Delivery | CELANESE EVA PERFORMANCE POLYMERS LLC | 2026-04-09 | — | — | US | disclosed |
| EP-4312951-A1 | IMPLANTABLE MEDICAL DEVICE FOR THE DELIVERY OF NUCLEIC ACID-ENCAPSULATED PARTICLES | Celanese EVA Performance Polymers LLC (US) | 2024-02-07 | — | — | EP | disclosed |
| WO-2022212300-A1 | IMPLANTABLE MEDICAL DEVICE FOR THE DELIVERY OF NUCLEIC ACID-ENCAPSULATED PARTICLES | CELANESE EVA PERFORMANCE POLYMERS LLC (US) | 2022-10-06 | — | — | WO | disclosed |
| US-20220313616-A1 | Implantable Medical Device for the Delivery of Nucleic Acid-Encapsulated Particles | CELANESE EVA PERFORMANCE POLYMERS LLC | 2022-10-06 | — | — | US | disclosed |
| WO-2015193669-A1 | DIAGNOSTIC AND THERAPEUTIC METHOD INVOLVING THE AUTOTAXIN-LYSOPHOSPHATIDIC ACID SIGNALLING PATHWAY | BABRAHAM INSTITUTE (GB) | 2015-12-23 | — | — | WO | disclosed |
| US-8703179-B2 | Mucosal formulation | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2014-04-22 | — | — | US | disclosed |
| WO-2007133261-A1 | MUCOSAL FORMULATION | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2007-11-22 | — | — | WO | disclosed |
| US-20070264206-A1 | Mucosal formulation | KIMBERLY-CLARK WORLDWIDE, INC. | 2007-11-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260097150-A1 | Implantable Device for Treating an Ocular Condition | P4HTM, ITGAM, TIMM44 | SMPD1 2048/4885PTPN1 2486/4885FDPS 4440/4885 |
| US-20260096984-A1 | Implantable Device for Administering a Therapeutic Agent | GHITM, O60361, P4HTM | SMPD1 1091/4885PTPN1 1784/4885FDPS 4697/4885 |
| US-20070264206-A1 | Mucosal formulation | MUC1, CHMP4B, VMA21 | SMPD1 145/4885PTPN1 3955/4885FDPS 2883/4885 |
| US-20260096985-A1 | Injectable Composition For Drug Delivery | SAMM50, OPRM1, IRAK4 | SMPD1 1480/4885PTPN1 774/4885FDPS 3288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.